Biofrontera (BFRI) Total Non-Current Liabilities (2020 - 2025)

Biofrontera's Total Non-Current Liabilities history runs 6 years deep, the most recent figure standing at $18.1 million for Q4 2025.

• On a quarterly basis, Total Non-Current Liabilities rose 10.09% year-over-year to $18.1 million in Q4 2025; TTM through Dec 2025 was $18.1 million, a 10.09% increase from a year earlier, with the FY2025 full-year figure at $18.1 million, up 10.09% from the prior year.
• Total Non-Current Liabilities improved to $18.1 million in Q4 2025 per BFRI's latest filing, from $18.0 million in the prior quarter.
• Across five years, Total Non-Current Liabilities topped out at $29.0 million in Q4 2021 and bottomed at -$9.4 million in Q2 2023.
• The 5-year median for Total Non-Current Liabilities is $18.0 million (2025), against an average of $16.2 million.
• Across the five-year window, Total Non-Current Liabilities jumped 441.27% in 2022 and plunged 133.23% in 2023, its largest moves.
• Year by year, Total Non-Current Liabilities stood at $29.0 million in 2021, then fell by 7.03% to $27.0 million in 2022, then declined by 29.85% to $18.9 million in 2023, then slipped by 13.27% to $16.4 million in 2024, then rose by 10.09% to $18.1 million in 2025.
• Per Business Quant, the three latest BFRI Total Non-Current Liabilities figures stand at $18.1 million (Q4 2025), $18.0 million (Q3 2025), and $24.8 million (Q2 2025).